Are injectable polynucleotides effective for skin rejuvenation?

Do Polynucleotides Injectables Work for Skin Rejuvenation?

Yes, injectable polynucleotides are effective for skin rejuvenation, demonstrating statistically significant improvements in wrinkles, skin texture, elasticity, and overall skin quality, though the evidence base remains limited by small sample sizes and lack of standardization. 1

Mechanism of Action

Polynucleotides work through regenerative properties that stimulate tissue repair and enhance dermal quality:

• Growth factor stimulation – PN injections regulate essential processes including angiogenesis, cell migration, cell proliferation, and collagen deposition in the dermis 2
• Fibroblast activation – Polynucleotides enhance fibroblast vitality and activity, leading to improved dermal hydration and elasticity 3
• Collagen synthesis – Treatment leads to increased dermal thickness, neocollagenesis, and better-organized collagen bundles 2

Clinical Efficacy: What the Evidence Shows

Skin Quality Improvements

• Overall skin quality improved significantly from baseline (7.0 ± 1.06) to follow-up (7.8 ± 0.99) in facial middle third rejuvenation studies 3
• Wrinkles and roughness decreased by 17.1% with PN treatment 3
• Skin elasticity increased by 39.6% 3
• Skin brightness improved by 51.1% 3
• Pore volume and roughness showed higher improvement rates with PN compared to hyaluronic acid alone 4

Comparative Performance

• PN versus hyaluronic acid – In split-face trials, PN filler showed comparable efficacy to non-crosslinked HA for periorbital rejuvenation, with PN demonstrating superior sustained improvement in skin elasticity and hydration over time 4
• PN as priming agent – When used sequentially before HA filler injections, PN significantly improved wrinkles and skin texture at 6 weeks, 3 months, and 6 months, with HA levels remaining significantly higher in PN-primed areas 5

Treatment Protocols

Standard Administration

• Intradermal injection technique – PN is delivered as intradermal gel injections into target areas 3
• Typical dosing – 2-4 ml per treatment session, with concentrations ranging from 7.5-20 mg/ml depending on treatment area 3
• Treatment schedule – Most protocols involve 3 treatment sessions at baseline, 3 weeks, and 6 weeks 3

Alternative Delivery Methods

• Needle-free jet injection – CureJet system demonstrated significantly higher patient satisfaction, lower pain scores, and more pronounced improvement in pores and wrinkles compared to traditional needle injection 6

Duration of Effect and Follow-Up

• Short-term results – Improvements visible within 6 weeks of initial treatment 5
• Medium-term maintenance – Benefits sustained through 6 months in most studies 5, 3
• Long-term data – Limited evidence beyond 6 months; further research needed to establish durability 1

Safety Profile

• Adverse events are generally mild and transient, including injection-site pain, erythema, burning sensation, and bruising 2
• No serious adverse events reported across 219 patients in systematic review 1
• Well-tolerated with moderate to high patient satisfaction scores 1

Combination Strategies

While the question focuses on polynucleotides alone, it's worth noting that PN combined with hyaluronic acid (50:50 mix) produces superior outcomes compared to either treatment independently, with 20-24% improvement in facial appearance scores versus 9-11% with PRP alone 7, 2. However, PN monotherapy remains effective as a standalone treatment 5, 3.

Important Limitations and Caveats

Evidence Quality Concerns

• Small sample sizes – Most studies include fewer than 50 patients, limiting generalizability 1
• Lack of standardization – Significant variation exists in injection techniques, treatment areas, dosing protocols, and outcome measurements 1
• Study quality – Systematic review identified only low to moderate quality evidence 1
• Limited long-term data – Most studies follow patients for only 6 months or less 1

Clinical Practice Considerations

• Heterogeneous protocols – No consensus exists on optimal dosing, injection depth, or treatment intervals 1
• Variable formulations – Different PN products may contain varying concentrations and additional components (e.g., hyaluronic acid, mannitol) 3
• Need for rigorous trials – High-quality, double-blind randomized controlled trials with sufficient follow-up are essential to establish definitive protocols 2, 1

Bottom Line for Clinical Practice

Polynucleotide injections represent a promising and effective option for skin rejuvenation with a favorable safety profile, particularly for patients seeking improvements in skin texture, elasticity, wrinkles, and overall skin quality 1, 3. The treatment is well-tolerated with minimal downtime and transient side effects 1. However, clinicians should counsel patients that while results are statistically significant and clinically meaningful, the evidence base is still evolving, and optimal protocols remain to be definitively established 1.